Company / Current Liabilities per Share
Janux Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.40
FY2025
5-year range
$0.30 / $0.54
FY2021-FY2025
Trend
+24.2%
vs FY2024
Sector context
#165 of 212
Health Care
What the data says
Janux Therapeutics, Inc.'s current liabilities per share of $0.40 is lower than 78% of companies in the Health Care sector (FY2025). Increased from $0.30 to $0.40 over the past 2 years.
Based on SEC 10-K filings.
0.40 in FY2025 with a 5-year CAGR of -35.0%.
Increased from $0.30 to $0.40 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- -35.0%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 212This company $0.40 Sector average $15.64
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 24.2% year-over-year.
- Ranks #165 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | +24.2% |
| FY2024 | $0.32 | +9.7% |
| FY2023 | $0.30 | -25.6% |
| FY2022 | $0.40 | -26.8% |
| FY2021 | $0.54 | -84.4% |
| FY2020 | $3.48 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026